Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Juan Ambrosioni and Josep Mensa.
Juan Ambrosioni
Connection Strength
0.294
Josep Mensa
  1. Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. J Antimicrob Chemother. 2021 11 12; 76(12):3296-3302.
    View in: PubMed
    Score: 0.061
  2. Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study. BMJ Open. 2021 08 17; 11(8):e040775.
    View in: PubMed
    Score: 0.060
  3. Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection. Rev Esp Quimioter. 2021 Jun; 34(3):238-244.
    View in: PubMed
    Score: 0.059
  4. Real-life use of remdesivir in hospitalized patients with COVID-19. Rev Esp Quimioter. 2021 Apr; 34(2):136-140.
    View in: PubMed
    Score: 0.058
  5. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021 Jan; 27(1):83-88.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.